IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 47 filers reported holding IKENA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $781,000 | -19.9% | 220,082 | 0.0% | 0.10% | 0.0% |
| Q2 2022 | $975,000 | -44.4% | 220,082 | -23.5% | 0.10% | -16.2% |
| Q1 2022 | $1,754,000 | -51.4% | 287,621 | 0.0% | 0.12% | -40.3% |
| Q4 2021 | $3,607,000 | -15.9% | 287,621 | -15.4% | 0.20% | +5.9% |
| Q3 2021 | $4,290,000 | -19.1% | 339,951 | -10.0% | 0.18% | -12.7% |
| Q2 2021 | $5,301,000 | -45.0% | 377,551 | +10.6% | 0.21% | -37.8% |
| Q1 2021 | $9,639,000 | – | 341,212 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $30,611,000 | 3.87% |
| Omega Fund Management, LLC | 2,249,123 | $13,720,000 | 2.81% |
| CHI Advisors LLC | 814,755 | $4,970,000 | 2.11% |
| BVF INC/IL | 2,501,571 | $15,260,000 | 0.61% |
| Artal Group S.A. | 1,549,513 | $9,452,000 | 0.40% |
| Orbimed Advisors | 2,933,941 | $17,897,000 | 0.29% |
| Logos Global Management LP | 178,281 | $1,088,000 | 0.14% |
| HealthCor Management, L.P. | 287,621 | $1,754,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 792,077 | $4,832,000 | 0.02% |
| Point72 Asset Management, L.P. | 348,696 | $2,127,000 | 0.01% |